Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11317376 | 0.93 | GPR84 (0.57) | GPR84FFAR1CA1NAAAZDHHC7 | |
| SCHEMBL27513859 | 0.91 | GPR84 (0.61) | GPR84FFAR1NAAAZDHHC7 | |
| SCHEMBL5676266 | 0.91 | GPR84 (0.61) | GPR84FFAR1NAAAZDHHC7 | |
| SCHEMBL18171894 | 0.91 | GPR84 (0.61) | GPR84FFAR1NAAAZDHHC7 | |
| SCHEMBL27765058 | 0.91 | GPR84 (0.61) | GPR84FFAR1NAAAZDHHC7 | |
| SCHEMBL27968449 | 0.86 | GPR84 (0.55) | GPR84FFAR1NAAAZDHHC7 | |
| SCHEMBL27392642 | 0.86 | — | — | |
| SCHEMBL8463037 | 0.84 | CA2 (0.57) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL6663357 | 0.84 | GPR84 (0.50) | GPR84FFAR1CA2CA1TSHR | |
| Glycerin SCHEMBL5583303 | 0.83 | GPR84 (0.52) | GPR84FFAR1ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102295579-A | Synthesis process for (R)-4-cyano-3-hydroxybutyric acid ethyl ester | ANQING JINQUAN PHARM CO LTD | 2011-12-28 | — | — | CN | claimed |
| CN-101821404-A | Microbial kinetic resolution of ethyl 3, 4-epoxybutyrate | AGENCY SCIENCE TECH & RES | 2010-09-01 | — | — | CN | claimed |
| US-20240100810-A1 | RESIN COMPOSITION, OPTICAL LAMINATE, OPTICAL ARTICLE, LENS AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2024-03-28 | — | — | US | disclosed |
| CN-115916463-A | Microspheres containing polymerizable functional groups | 株式会社德山 | 2023-04-04 | — | — | CN | disclosed |
| CN-115768746-A | Compound for optical material, curable composition, cured product, and optical article | 株式会社德山 | 2023-03-07 | — | — | CN | disclosed |
| US-11578174-B2 | Polyrotaxane, production method therefor, and optical composition containing said polyrotaxane | TOKUYAMA CORPORATION (JP) | 2023-02-14 | — | — | US | disclosed |
| US-20230029768-A1 | PROCESS FOR PRODUCING CYCLOHEXANOL AND CYCLOHEXANONE | BASF SE (DE) | 2023-02-02 | — | — | US | disclosed |
| CN-115428128-A | Hollow microspheres | 株式会社德山 | 2022-12-02 | — | — | CN | disclosed |
| EP-4077252-A1 | PROCESS FOR PRODUCING CYCLOHEXANOL AND CYCLOHEXANONE | BASF SE (DE) | 2022-10-26 | — | — | EP | disclosed |
| CN-114845983-A | Process for preparing cyclohexanol and cyclohexanone | 巴斯夫欧洲公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-111154056-B | Optical composition containing polyrotaxane | 株式会社德山 | 2021-12-21 | — | — | CN | disclosed |
| US-20120101009-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT STREAM DERIVATIVES AND METHODS FOR USING THE SAME | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-04-26 | — | — | US | disclosed |
| US-20120064252-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT DERIVATIVES AND METHODS FOR USING THE SAME | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-03-15 | — | — | US | disclosed |
| CN-102295579-A | Synthesis process for (R)-4-cyano-3-hydroxybutyric acid ethyl ester | ANQING JINQUAN PHARM CO LTD | 2011-12-28 | — | — | CN | disclosed |
| EP-2376422-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT STREAM DERIVATIVES AND METHODS FOR USING THE SAME | Invista Technologies S.A R.L. (CH) | 2011-10-19 | — | — | EP | disclosed |
| EP-2376421-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT DERIVATIVES AND METHODS FOR USING THE SAME | Invista Technologies S.A R.L. (CH) | 2011-10-19 | — | — | EP | disclosed |
| CN-101821404-A | Microbial kinetic resolution of ethyl 3, 4-epoxybutyrate | AGENCY SCIENCE TECH & RES | 2010-09-01 | — | — | CN | disclosed |
| WO-2010071761-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT STREAM DERIVATIVES AND METHODS FOR USING THE SAME | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010071759-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT DERIVATIVES AND METHODS FOR USING THE SAME | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2010-06-24 | — | — | WO | disclosed |
| US-6313316-B1 | 2,5-BIS(ISOCYANATOALKYLTHIOALKYL)-1,4-DITHIAN DERIVATIVES; HIGH REFRACTIVE INDEX; HEAT RESISTANCE, RADIATION TRANSPARENT; OPTICAL FILTERS AND FIBERS; EYEGLASSES | HOYA CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101009-A1 | CYCLOHEXANE OXIDATION PROCESS BYPRODUCT STREAM DERIVATIVES AND METHODS FOR USING THE SAME | DECR1, SIGMAR1, NOP2 | GPR84 2616/4885FFAR1 6/4885CA2 1649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.